Jim Simons Teva Pharmaceutical Industries LTD Transaction History

Renaissance Technologies LLC

$56.7 Billion
Q2 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Renaissance Technologies LLC holds 8,728,563 shares of TEVA stock, worth $153 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

8,728,563

Previous 7,697,163 13.4%

Holding current value

$153 Million

Previous $109 Million 30.6%

% of portfolio

0.25%

Previous 0.17%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$12.78 - $17.4 $13.2 Million - $17.9 Million	1,031,400 Added 13.4%	8,728,563 $142 Million
Q1 2024 May 13, 2024	BUY	$10.67 - $14.43 $24.1 Million - $32.6 Million	2,261,800 Added 41.61%	7,697,163 $109 Million
Q4 2023 Feb 13, 2024	BUY	$8.12 - $10.63 $11.5 Million - $15.1 Million	1,417,463 Added 35.28%	5,435,363 $56.7 Million
Q3 2023 Nov 14, 2023	SELL	$7.48 - $10.7 $18.9 Million - $27 Million	-2,522,160 Reduced 38.56%	4,017,900 $41 Million
Q2 2023 Aug 11, 2023	BUY	$7.2 - $9.47 $38,880 - $51,138	5,400 Added 0.08%	6,540,060 $49.2 Million
Q1 2023 May 12, 2023	BUY	$8.36 - $11.37 $16.3 Million - $22.1 Million	1,944,097 Added 42.35%	6,534,660 $57.8 Million
Q4 2022 Feb 13, 2023	BUY	$7.95 - $9.48 $1.99 Million - $2.38 Million	250,563 Added 5.77%	4,590,563 $41.9 Million
Q3 2022 Nov 14, 2022	BUY	$6.86 - $11.95 $1.34 Million - $2.33 Million	195,037 Added 4.71%	4,340,000 $35 Million
Q2 2022 Aug 12, 2022	BUY	$7.38 - $10.4 $11.5 Million - $16.2 Million	1,555,800 Added 60.09%	4,144,963 $31.2 Million
Q1 2022 May 13, 2022	BUY	$7.33 - $9.39 $11.9 Million - $15.2 Million	1,623,966 Added 168.25%	2,589,163 $24.3 Million
Q4 2021 Feb 11, 2022	BUY	$7.9 - $10.19 $7.34 Million - $9.47 Million	929,397 Added 2596.08%	965,197 $7.73 Million
Q3 2021 Nov 12, 2021	SELL	$8.38 - $10.18 $7.63 Million - $9.27 Million	-910,563 Reduced 96.22%	35,800 $349,000
Q2 2021 Aug 13, 2021	BUY	$9.9 - $11.56 $9.37 Million - $10.9 Million	946,363 New	946,363 $9.37 Million
Q4 2020 Feb 10, 2021	SELL	$8.61 - $11.04 $9.81 Million - $12.6 Million	-1,139,163 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$8.57 - $12.69 $25.3 Million - $37.5 Million	-2,952,300 Reduced 72.16%	1,139,163 $10.3 Million
Q2 2020 Aug 13, 2020	BUY	$8.12 - $13.12 $7.25 Million - $11.7 Million	892,431 Added 27.9%	4,091,463 $50.4 Million
Q1 2020 May 14, 2020	BUY	$6.69 - $13.45 $6.47 Million - $13 Million	967,036 Added 43.33%	3,199,032 $28.7 Million
Q4 2019 Feb 13, 2020	SELL	$6.53 - $10.72 $30.7 Million - $50.5 Million	-4,706,667 Reduced 67.83%	2,231,996 $21.9 Million
Q3 2019 Nov 13, 2019	SELL	$6.16 - $9.6 $17.5 Million - $27.3 Million	-2,847,400 Reduced 29.1%	6,938,663 $47.7 Million
Q2 2019 Aug 12, 2019	BUY	$8.12 - $15.72 $58.1 Million - $113 Million	7,159,900 Added 272.64%	9,786,063 $90.3 Million
Q1 2019 May 14, 2019	SELL	$15.58 - $20.01 $67.2 Million - $86.4 Million	-4,315,822 Reduced 62.17%	2,626,163 $41.2 Million
Q4 2018 Feb 13, 2019	BUY	$14.59 - $23.84 $101 Million - $165 Million	6,941,985 New	6,941,985 $107 Million

Others Institutions Holding TEVA

# of Institutions

617

Shares Held

563M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account